澳洲市場個股詳情
PAR Paradigm Biopharmaceuticals Ltd
- 0.280
- -0.010-3.45%
延時20分鐘行情已收盤 07/02 16:00 (悉尼)
9810.20萬總市值-1564市盈率(靜)
0.315最高價0.275最低價148.22萬股成交量0.300今開0.290昨收44.45萬成交額1.02052周最高0.47%換手率3.50億總股本0.21052周最低-0.233每股收益TTM8758.30萬流通值4.500歷史最高虧損市盈率(靜)3.13億流通股0.210歷史最低-0.179每股收益(静)13.79%振幅--股息TTM2.89市淨率1股每手--股息率TTM
Paradigm Biopharmaceuticals Ltd關鍵統計數據
季報+年報
顯示同比
| (FY)2023/06/30 | (FY)2022/06/30 | (FY)2021/06/30 | (FY)2020/06/30 | (FY)2019/06/30 | (FY)2018/06/30 | (FY)2017/06/30 | (FY)2016/06/30 | |
|---|---|---|---|---|---|---|---|---|
| 營業總收入 | -40.98%4.68萬 | 285.52%7.92萬 | 2.06萬 | |||||
| 營業收入 | -40.98%4.68萬 | 285.52%7.92萬 | --2.06萬 | ---- | ---- | ---- | ---- | ---- |
| 主營業務成本 | -86.90%1.88萬 | 45.00%14.38萬 | 9.91萬 | |||||
| 毛利 | 143.29%2.79萬 | 17.89%-6.45萬 | -7.86萬 | |||||
| 營業費用 | 25.33%6,006.64萬 | 10.65%4,792.6萬 | 152.21%4,331.2萬 | 67.98%1,717.33萬 | 14.33%1,022.36萬 | 45.61%894.2萬 | 42.12%614.1萬 | 432.11萬 |
| 銷售和管理費用 | -17.26%656.45萬 | -9.30%793.42萬 | 109.96%874.82萬 | 79.71%416.66萬 | -0.58%231.85萬 | 23.30%233.21萬 | 30.39%189.14萬 | --145.06萬 |
| -管理費用 | -17.26%656.45萬 | -9.30%793.42萬 | 109.96%874.82萬 | 79.71%416.66萬 | -0.58%231.85萬 | 23.30%233.21萬 | 30.39%189.14萬 | --145.06萬 |
| 研發費用 | 35.03%5,267.92萬 | 16.39%3,901.2萬 | 161.98%3,351.69萬 | 62.01%1,279.36萬 | 19.75%789.67萬 | 55.79%659.46萬 | 47.59%423.3萬 | --286.8萬 |
| 折舊攤銷及損耗 | ---- | -70.98%6.1萬 | -1.44%21.01萬 | 2,452.92%21.31萬 | -45.62%8,348 | -7.67%1.54萬 | 555.90%1.66萬 | --2,535 |
| -折舊及攤銷 | ---- | -70.98%6.1萬 | -1.44%21.01萬 | 2,452.92%21.31萬 | -45.62%8,348 | -7.67%1.54萬 | 555.90%1.66萬 | --2,535 |
| 其他營業費用 | -10.47%82.27萬 | 9.80%91.89萬 | --83.69萬 | ---- | ---- | ---- | ---- | ---- |
| 營業利潤 | -25.10%-6,003.85萬 | -10.60%-4,799.05萬 | -152.66%-4,339.06萬 | -67.98%-1,717.33萬 | -14.33%-1,022.36萬 | -45.61%-894.2萬 | -42.12%-614.1萬 | -432.11萬 |
| 營業外利息收入與支出淨額 | 5,897.84%138.62萬 | -86.52%2.31萬 | -82.21%17.14萬 | 268.15%96.35萬 | 385.56%26.17萬 | 110.37%5.39萬 | -75.26%2.56萬 | 10.36萬 |
| 營業外利息收入 | 2,610.61%140.26萬 | -75.26%5.17萬 | -79.04%20.91萬 | 281.20%99.76萬 | 385.56%26.17萬 | 110.37%5.39萬 | -75.26%2.56萬 | --10.36萬 |
| 營業外利息支出 | -42.67%1.64萬 | -24.09%2.86萬 | 10.40%3.77萬 | --3.42萬 | ---- | ---- | ---- | ---- |
| 其他淨收入/費用 | -22.12%674.23萬 | -0.63%865.69萬 | 135.60%871.2萬 | 165.17%369.78萬 | -311.52%-567.4萬 | 47.12%268.25萬 | 41.28%182.33萬 | 129.06萬 |
| 特殊收入（費用） | ---- | ---- | ---- | ---- | ---692.9萬 | ---- | ---- | ---- |
| -減：資本性資產減值 | ---- | ---- | ---- | ---- | --692.9萬 | ---- | ---- | ---- |
| 其他營業外收入（費用） | -22.12%674.23萬 | -0.63%865.69萬 | 135.60%871.2萬 | 194.66%369.78萬 | -53.22%125.5萬 | 47.12%268.25萬 | 41.28%182.33萬 | --129.06萬 |
| 稅前利潤 | -32.26%-5,191萬 | -14.44%-3,924.96萬 | -178.86%-3,429.72萬 | 21.30%-1,229.89萬 | -152.45%-1,562.75萬 | -44.79%-619.02萬 | -46.20%-427.54萬 | -292.44萬 |
| 所得稅 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 除稅後的權益收益 | ||||||||
| 除稅後利潤 | -32.26%-5,191萬 | -14.44%-3,924.96萬 | -178.86%-3,429.72萬 | 21.30%-1,229.89萬 | -152.45%-1,562.75萬 | -44.79%-619.02萬 | -46.20%-427.54萬 | -292.44萬 |
| 持續經營利潤 | -32.26%-5,191萬 | -14.44%-3,924.96萬 | -178.86%-3,429.72萬 | 21.30%-1,229.89萬 | -152.45%-1,562.75萬 | -44.79%-619.02萬 | -46.20%-427.54萬 | ---292.44萬 |
| 歸屬於少數股東的淨利潤 | ||||||||
| 歸屬於母公司的淨利潤 | -32.26%-5,191萬 | -14.44%-3,924.96萬 | -178.86%-3,429.72萬 | 21.30%-1,229.89萬 | -152.45%-1,562.75萬 | -44.79%-619.02萬 | -46.20%-427.54萬 | -292.44萬 |
| 優先股派息 | ||||||||
| 其他優先股派息 | ||||||||
| 歸屬於普通股股東的淨利潤 | -32.26%-5,191萬 | -14.44%-3,924.96萬 | -178.86%-3,429.72萬 | 21.30%-1,229.89萬 | -152.45%-1,562.75萬 | -44.79%-619.02萬 | -46.20%-427.54萬 | -292.44萬 |
| 基本每股收益 | -9.98%-0.1792 | -0.78%-0.1629 | -173.53%-0.1616 | 44.01%-0.0591 | -99.37%-0.1055 | -22.15%-0.0529 | -24.17%-0.0433 | -0.0349 |
| 稀釋每股收益 | -9.98%-0.1792 | -0.78%-0.1629 | -173.53%-0.1616 | 44.01%-0.0591 | -99.37%-0.1055 | -22.15%-0.0529 | -24.17%-0.0433 | -0.0349 |
| 每股派息 | ||||||||
| 會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
分析
目標價預測
暫無數據
熱議
澳大利亞
綜合熱度
股票代碼
最新價
漲跌幅